2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
JACC · 2026-05 · 87 (19) · 2624-2757
DOI: 10.1016/j.jacc.2025.11.016 ↗Kurz gefasst
Leitlinie in der Zeitschrift JACC, 2026-05. Verfasst von Roger S Blumenthal und 32 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dyslipidemias, Cardiology. Die Arbeit wurde bisher 400-mal zitiert (Crossref) und nennt 1012 Literaturangaben.
Abstract (Originalsprache)
AIM: The "2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia" retires and replaces the "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." METHODS: A comprehensive literature search was conducted from October 2024 to December 2024 to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., Gianos, E., Gluckman, T. J., Gradney, K. F., Isiadinso, I., Lloyd-Jones, D. M., Marrs, J. C., Martin, S. S., McLain, K. H., Mehta, L. S., …, & Wilkins, J. T. (2026). 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. JACC, 87(19), 2624-2757. https://doi.org/10.1016/j.jacc.2025.11.016
Vancouver
Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. JACC. 2026;87(19):2624-2757. doi:10.1016/j.jacc.2025.11.016
BibTeX
@article{Blumenthal2026,
author = {Blumenthal, Roger S and Morris, Pamela B and Gaudino, Mario and Johnson, Heather M and Anderson, Timothy S and Bittner, Vera A and Blankstein, Ron and Brewer, LaPrincess C and Cho, Leslie and de Ferranti, Sarah D and Gianos, Eugenia and Gluckman, Ty J and Gradney, Kristen F and Isiadinso, Ijeoma and Lloyd-Jones, Donald M and Marrs, Joel C and Martin, Seth S and McLain, Kellie H and Mehta, Laxmi S and Mora, Samia and Mulugeta, Wudeneh M and Natarajan, Pradeep and Navar, Ann Marie and Orringer, Carl E and Polonsky, Tamar S and Reynolds, Harmony R and Saseen, Joseph J and Shapiro, Michael D and Soffer, Daniel E and Tynes, Sheila A and Villavaso, Chloé D and Virani, Salim S and Wilkins, John T},
title = {2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia},
journal = {JACC},
year = {2026},
volume = {87},
number = {19},
pages = {2624--2757},
doi = {10.1016/j.jacc.2025.11.016}
}
EUVIMED